These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9121006)

  • 1. [Development of in vivo gene transfer methods towards future gene therapy].
    Kaneda Y; Morishita R
    Rinsho Byori; 1997 Feb; 45(2):99-105. PubMed ID: 9121006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene therapy of cardiovascular disorders].
    Kaneda Y; Morishita R
    Hum Cell; 1999 Sep; 12(3):109-14. PubMed ID: 10695017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusigenic viral liposome for gene therapy in cardiovascular diseases.
    Dzau VJ; Mann MJ; Morishita R; Kaneda Y
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11421-5. PubMed ID: 8876150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
    Aoki M; Morishita R; Muraishi A; Moriguchi A; Sugimoto T; Maeda K; Dzau VJ; Kaneda Y; Higaki J; Ogihara T
    J Mol Cell Cardiol; 1997 Mar; 29(3):949-59. PubMed ID: 9152856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.
    Lamfers ML; Lardenoye JH; de Vries MR; Aalders MC; Engelse MA; Grimbergen JM; van Hinsbergh VW; Quax PH
    Gene Ther; 2001 Apr; 8(7):534-41. PubMed ID: 11319620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of non-viral gene delivery system and its applications].
    Kaneda Y
    Nihon Rinsho; 1996 Oct; 54(10):2829-38. PubMed ID: 8914452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of HVJ envelope vector and its application to gene therapy.
    Kaneda Y; Yamamoto S; Nakajima T
    Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium.
    Yonemitsu Y; Kaneda Y; Muraishi A; Yoshizumi T; Sugimachi K; Sueishi K
    Gene Ther; 1997 Jul; 4(7):631-8. PubMed ID: 9282164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient transfer of oligonucleotides and plasmid DNA into the whole heart through the coronary artery.
    Sawa Y; Kaneda Y; Bai HZ; Suzuki K; Fujimoto J; Morishita R; Matsuda H
    Gene Ther; 1998 Nov; 5(11):1472-80. PubMed ID: 9930300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide.
    Yoshida M; Yamamoto N; Nitta T; Uehara T; Terao R; Hatano E; Iimuro Y; Yamaoka Y
    J Surg Res; 2002 Feb; 102(2):95-101. PubMed ID: 11796004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of restenosis by gene therapy.
    Kaneda Y; Morishita R; Dzau VJ
    Ann N Y Acad Sci; 1997 Apr; 811():299-308; discussion 308-10. PubMed ID: 9186606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine.
    Okamoto T; Kaneda Y; Yuzuki D; Huang SK; Chi DD; Hoon DS
    Gene Ther; 1997 Sep; 4(9):969-76. PubMed ID: 9349434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular molecular genetics and gene therapy. Introduction to the terminology and technique].
    Eppenberger HM
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1716-20. PubMed ID: 8966504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
    Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
    J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.
    von der Leyen HE; Mann MJ; Dzau VJ
    Semin Interv Cardiol; 1996 Sep; 1(3):209-14. PubMed ID: 9552513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular gene therapy].
    Hansen PR
    Ugeskr Laeger; 1997 Nov; 159(48):7124-8. PubMed ID: 9417717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma.
    Mabuchi E; Shimizu K; Miyao Y; Kaneda Y; Kishima H; Tamura M; Ikenaka K; Hayakawa T
    Gene Ther; 1997 Aug; 4(8):768-72. PubMed ID: 9338004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of cultured human Tenon's fibroblastic cells by targeting the E2F transcription factor.
    Akimoto M; Hangai M; Okazaki K; Kogishi J; Honda Y; Kaneda Y
    Exp Eye Res; 1998 Oct; 67(4):395-401. PubMed ID: 9820786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel bubble liposome and ultrasound-mediated gene transfer to ocular surface: RC-1 cells in vitro and conjunctiva in vivo.
    Yamashita T; Sonoda S; Suzuki R; Arimura N; Tachibana K; Maruyama K; Sakamoto T
    Exp Eye Res; 2007 Dec; 85(6):741-8. PubMed ID: 17889849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.